A CCK8 kit (CK04) was employed to measure the cell viability. Briefly, the cells were exposed to indicated concentrations of t-BHP and/or indicated concentrations of DPDS for 24 h. After that, 10 μL of CCK8 (Dojindo, Japan) was added to each well, followed by a further incubation for 2 h. Finally, a multifunctional microplate reader (BioTek, Synergy2, Winooski, VT, USA) was employed to measure the OD value at 450 nm of each well.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.